Today, procedures performed by endoscopy are very limited. The majority are focused on simple diagnostics or very basic endolumenal procedures such as polypectomy.

Minos Medical believes that by advancing instrumentation and combining this with innovative new therapeutic approaches, far more exciting and important endolumenal therapies can be created which will eliminate the need for traditional surgery.

Minos is developing entire new therapies and the instrumentation to achieve them.

COLONIC DIVERTICULAR DISEASE:

Diverticulosis and diverticulitis are diseases that affect more than 110 million people in the western world. Over 3 million people get complex diverticulosis requiring secondary care.

With no alternatives today, many patients end up undergoing a hemicolectomy and living with a colostomy.
Minos is developing a brand new therapy to treat this disease at routine colonoscopy in a simple, patient friendly outpatient procedure.

Minos has developed a simple system, which will close off the small diverticulum (out pouches) which cause pain and bleeding. The aim is to close off up to 15 diverticulum per session, and over multiple sessions reduce dramatically the number of diverticulum.

This new therapy is in a pre-clinical phase.

APPENDICEAL DISEASE:

Upwards of 90 million Americans have detectable appendiceal disease which annually results in 450,000 acute appendectomies (800,000 in the western world).

Minos Medical is developing revolutionary new systems to treat the appendix from inside the colon - with no surgical incisions.

The aim is to be able to diagnose and treat appendiceal disease at all stages - from asymptomatic to symptomatic. Elective to acute interventions. By combining our revolutionary new tools with cutting edge imaging equipment, we aim to treat the appendix with one of the following methods:

a) Internal Appendoscopy and interventions. By removing blockages or ablating the appendix from within.

b) Removing the appendix with a revolutionary inverting and removal device.

These two new therapies change the way we think of appendiceal disease from just an acute disease (as treated today) to a broader pathology of chronic states that can be treated earlier.

Appendoectomy is currently under ongoing clinical trials.

ALL ABOUT ACCESS:

Advancing endolumenal therapies is all about being able to get Rapid - Repeatable Access.

Both DiverLite and Appendoectomy rely upon a special new access system called MegaChannel. This is a 22mm diameter access channel that is advanced into the colon using standard colonoscopy techniques. But once in place it acts as a rapid super-highway to allow multiple instruments to be passed into the colon, instrument exchanges, scope exchanges and distal bowel counter forces to be applied.

MegaChannel is already in use around the world, being used in advanced procedures such as multiple polypectomies, right colon bleeding, difficult polyps, endolumenal stapling and suturing, stent placement and removal as well as endoscopic ultrasound.

Learn More Here

 

Megachannel has been published in several clinical trials, is both CE marked and FDA registered.